PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy

PsiOxus Therapeutics Ltd. (PsiOxus) and the Parker Institute for Cancer Immunotherapy (Parker Institute) announce a research project to investigate the use of PsiOxus’ virus-based gene therapy for treating solid tumors that have been historically resistant to immunotherapy.

Download Press Release